Sfoglia per Autore
The role of artificial intelligence in clinical trials in adult and pediatric rheumatology
2026 La Bella, S; Rebollo-Gimenez, A; Alongi, A; Capitoli, G; Breda, L; La Torre, F; Venerito, V; Ruperto, N
Artificial intelligence in rheumatology and paediatric rheumatology: insights from an international survey by EMEUNET
2026 La Bella, S; Rebollo-Giménez, A; Aouad, K; Gupta, L; Kragstrup, T; Bayraktar, D; Davergne, T; Cangelosi, D; Hügle, T; Knitza, J; Ruperto, N; Venerito, V; Bautista-Molano, W; Dey, D; El Maghraoui, A; Hmamouchi, I; Hoens, A; Li, L; Migowa, A; Treemarcki, E; Ziade, N; Alongi, A; Benavent, D
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab
2026 Ramanan, A; Ruperto, N; Foeldvari, I; Vega-Cornejo, G; Keller, S; Wang, R; Araujo, J; Sen, P; Marulkar, K; Tseng, J; Pitou, C; Quartier, P
Environmental determinants of juvenile idiopathic arthritis: current evidence and future directions
2026 La Bella, S; Alongi, A; Filocamo, G; Cattalini, M; Lanni, S; Marino, A; Minoia, F; Ruperto, N
A systematic review of juvenile dermatomyositis complicated by macrophage activation syndrome
2026 Rossano, M; Baldo, F; Vaienna, P; Lanni, S; Brusadelli, C; Bossi, G; La Bella, S; Ruperto, N; Filocamo, G; Minoia, F
Multimodal and fair artificial intelligence in paediatric rheumatology: challenges and opportunities for a holistic and equitable future
2026 Rebollo-Gimenez, A; La Bella, S; Matucci-Cerinic, C; Garcia-Alija, A; Gattorno, M; Alongi, A; Ruperto, N
Towards personalized treatment in juvenile idiopathic arthritis: moving beyond the trial-and-error strategy
2026 Marino, A; Pandolfi, M; Lommano, M; Costi, S; Baldo, F; La Bella, S; Chighizola, C; Ruperto, N; Caporali, R
Beyond randomized clinical trials in pediatric rheumatology: exploring the potential of target trial emulation
2026 Alongi, A; Alberto Scire, C; Bakewell, N; Cadarette, S; La Bella, S; Ruperto, N; Rebora, P
Recurrent pericarditis in children: evidence, controversies, and emerging perspectives
2026 Mauro, A; Baldassarre, P; Zicoia, M; Bizzi, E; Sandini, M; Ansuini, V; Spolidoro, G; Mascolo, R; Trotta, L; La Bella, S; Ruperto, N; Brucato, A; Bernardo, L
Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study
2026 Mastrolia, M; Pandiarajan, V; Cattalini, M; Taddio, A; Vergnano, S; Anton, J; Sontichai, W; Sozeri, B; Ozen, S; Rosina, S; Sanchez-Manubens, J; Haviv, R; Pal, P; Fonseca, A; Gagro, A; Bagri, N; Verdoni, L; Montin, D; Maggio, M; Thangaraj, A; Pilania, R; Mosquera, M; Calzada, J; Sittiwangkul, R; Ulu, K; Balik, Z; Bilginer, Y; Garrone, M; Patrone, E; Barbi, E; Ciacci, G; Barucci, A; Ruperto, N; Simonini, G
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
2026 Brunner, H; Alexeeva, E; Bandeira, M; Carrasco, R; Chaitow, J; Chiraseveenuprapund, P; Ting, T; Erguven, M; Gottlieb, B; Oliveira, S; Patel, P; Ozen, S; Saad Magalhaes, C; Penades, I; Gruben, D; Germino, R; Posner, H; Stockert, L; Martini, A; Lovell, D; Ruperto, N
Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis
2026 Mayer, A; Xiao, R; Brandon, T; Weiss, P; Aggarwal, A; Burgos-Vargas, R; Colbert, R; Horneff, G; Laxer, R; Minden, K; Ravelli, A; Ruperto, N; Smith, J; Stoll, M; Tse, S; Van Den Bosch, F; Maksymowych, W; Lambert, R; Biko, D; Chauvin, N; Francavilla, M; Jaremko, J; Herregods, N; Kasapcopur, O; Yildiz, M; Srinivasalu, H; Lovell, D; Nigrovic, P; Foeldvari, I; Klein-Gitelman, M; Ozen, S; Naden, R; Hendry, A; Joos, R
Decision Tree Analysis as a Preliminary Evidence-Based Tool for Identifying the Syndrome of Undifferentiated Recurrent Fever in Children Compared With Hereditary Recurrent Fevers and Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome
2026 Papa, R; Bovis, F; Federici, S; Palmeri, S; Bustaffa, M; Recchi, G; Bertelli, R; Caorsi, R; Volpi, S; Fuehner, S; Cam, V; Kozakova, A; Fingerhutova, S; Insalaco, A; Foell, D; Ozen, S; Ceccherini, I; Gattorno, M; Hofer, M; Vanoni, F; Anton, J; Arostegui, J; Barron, K; Ben-Chetrit, E; Brogan, P; Cantarini, L; Ceccherini, I; De Benedetti, F; Dedeoglu, F; Demirkaya, E; Frenke, J; Goldbach-Mansky, R; Gul, A; Hentgen, V; Hoffman, H; Kallinich, T; Kone-Paut, I; Kuemmerle-Deschner, J; Lachmann, H; Laxer, R; Livneh, A; Obici, L; Rowczenio, D; Russo, R; Shinar, Y; Simon, A; Toplak, N; Touitou, I; Uziel, Y; Van Gijn, M; Kastner, D; Martini, A; Sormani, M; Ruperto, N
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting
2026 Weiss, P; Ruperto, N; Quebe-Fehling, E; Shew, A; Pricop, L; Pieterse, C; Brunner, H
Outcome measures in paediatric rheumatology: the contribution of the Paediatric Rheumatology INternational Trials Organisation and the Pediatric Rheumatology Collaborative Study Group
2026 La Bella, S; Alongi, A; Brunner, H; Ravelli, A; Gattorno, M; Lovell, D; Giannini, E; Martini, A; Ruperto, N; Null, N
Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score
2025 Naddei, R; Ridella, F; Bovis, F; Trincianti, C; Avrusin, I; Januskeviciute, G; Burrone, M; Rebollo-Giménez, A; Minden, K; Ekelund, M; Barone, P; Rumba-Rozenfelde, I; Shafaie, N; Swart, J; Ruperto, N; Ravelli, A; Consolaro, A; Brunner, J; Fernandes, T; Appenzeller, S; Oliveira, S; Terreri, M; Tzaribachev, N; Hufnagel, M; Foeldvari, I; Horneff, G; Helling-Bakki, A; Herlin, T; Moreno, E; Anton, J; Mesa-Del-Castillo, P; Udaondo, C; Penades, I; Quartier, P; Brochard, K; Ramanan, A; Trachana, M; Orban, I; Hashkes, P; Simonini, G; Olivieri, A; Zulian, F; Montin, D; Peroni, D; Stanevicha, V; Cornejo, G; Wulffraat, N; Kamphuis, S; Gastanaga, M; Miraval, T; Oliveira-Ramos, F; Lazar, C; Nikishina, I; Alexeeva, E; Sarychev, A; Chasnyk, V; Grebenkina, L; Suwairi, W; Koskova, E; Ally, M; Louw, I; Breedt, J
Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force
2025 Rypdal, V; Brunner, H; Feldman, B; Ruperto, N; Aggarwal, A; Angeles-Han, S; Backstrom, M; Balay-Dustrude, E; Bracaglia, C; De Benedetti, F; Dolezalova, P; Garrone, M; Guzman, J; Horton, D; Laxer, R; Lovell, D; Lovli, T; Magni-Manzoni, S; Minoia, F; Morgan, E; Munro, J; Nordal, E; Normand, C; Pan, N; Patrone, E; Ravelli, A; Magalhaes, C; Sinha, R; Swart, J; Tarkiainen, M; Twilt, M; Vahasalo, P; Vastert, S; Vojinovic, J; Weiss, P; Gottlieb, B; Consolaro, A
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial
2025 Ruperto, N; Lovell, D; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Reyhan, I; Grebenkina, L; Tirosh, I; Imundo, L; Chiraseveenuprapund, P; Kingsbury, D; Sozeri, B; Vora, S; Prahalad, S; Zholobova, E; Roberts, K; Sawyerr, G; Blum, A; Shapiro, A; Diehl, A; Ebrahim, A; Klaus, P; Martini, A; Brunner, H
Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial
2025 Consolaro, A; Ruperto, N; Lovell, D; Synoverska, O; Abud-Mendoza, C; Spindler, A; Vyzhga, Y; Alexeeva, E; Chaitow, J; Chiraseveenuprapund, P; Lazariciu, I; Stockert, L; Cadatal, M; Diehl, A; Brunner, H
New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development
2025 De Lisa, R; de Andres-Trelles, F; Bax, R; Galluzzo, S; Alward, B; Thomson, A; Karres, D; Brunner, H; Ruperto, N; Egger, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile